Stock Events

Stock Events

Halozyme Therapeutics (HTI) Q4 2025 Earnings

3NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

0.96

1.21

1.47

1.72

Details

Expected EPS

1.630202

Actual EPS

1.72

Surprise EPS

0.09

Surprise Percent

+5.51%

Description

Halozyme Therapeutics (HTI) has reported earnings of 1.72 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.